Biomarker predicts future dementia in isolated rapid eye movement sleep behavior disorder

Takeaway

  • The deformation score of the brain-clinical signature, associated with iRBD, indicates increased likelihood of developing a synucleinopathy in the future.

Why this matters

    The pattern of brain-clinical features of iRBD may be used as a biomarker to predict the likelihood of developing cognitive impairment and could aid in targeted therapies.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.